Vnitr Lek 2009, 55(5):446-447

Výsledky léčby chronické hepatitidy C jsou v České republice srovnatelné s nejvyspělejšími státy světa - editorial

P. Husa
Klinika infekčních chorob Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Petr Husa, CSc.

Received: February 24, 2009; Published: May 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Husa P. Výsledky léčby chronické hepatitidy C jsou v České republice srovnatelné s nejvyspělejšími státy světa - editorial. Vnitr Lek. 2009;55(5):446-447.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Strader DB, Wright T, Thomas DL et al. Diagnosis, management, and treatment of hepatitis C. AASLD Practice Guideline. Hepatology 2004; 39: 1147-1171. Go to original source... Go to PubMed...
    2. Němeček V. Sérologický přehled ČR v roce 2001 - virová hepatitida A, B, C. Zprávy CEM 2003; 12 (příloha 1): 55-61.
    3. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 2008; 48: 148-162. Go to original source... Go to PubMed...
    4. Urbánek P, Husa P, Galský J et al. Standardní diagnostický a terapeutický postup chronické infekce virem hepatitidy C (HCV). Čas Lék Čes 2008; 146: 1-12.
    5. Husa P, Šlesinger P, Štroblová H et al. Závislost účinnosti léčby chronické hepatitidy C pegylovaným interferonem alfa-2a a ribavirinem na vstupních parametrech a virové kinetice v počátcích léčby. Klin Mikrobiol Inf Lék 2008; 14: 65-71.
    6. Fried MW, Shiffmann ML, Reddy KR et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-982. Go to original source... Go to PubMed...
    7. Hadziyannis SJ, Sette H jr, Morgan TR et al. Peginterferon alfa-2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004; 140: 346-355. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.